CHICAGO (Reuters) - Scientists have found a second gene that helps predict whether people with depression will respond to a commonly prescribed antidepressant, U.S. researchers said on Tuesday. On its own, the gene variation plays only a small role in predicting a patient’s response to Forest Laboratories Inc.'s Celexa, known generically as citalopram.
